Report updated Jun 10, 2026
RxHero - Master Top 250 Drugs
For healthcare students and professionals, including pharmacists, nurses, and medical students, preparing for standardized exams like NAPLEX or USMLE.
RxHero - Master Top 250 Drugs is an established medical app that is a paid app. With a 4.0/5 rating from 25 reviews, it shows polarized user reception.
What is RxHero - Master Top 250 Drugs?
RxHero is an educational game for healthcare students and professionals to learn the top 250 medications via quizzes, matching, and spelling.
Users hire RxHero to master pharmacology for standardized exams through adaptive learning, reducing the time required to memorize complex drug facts.
Current Momentum
v2.0
- Ships support for current iOS versions.
- Provides full drug library access.
What makes this app unique?
What Does It Look Like?
Loading...
What Are The Key Features?
Three-box system tracks mastery of drug facts and prioritizes unlearned content for review
Point-based ranking, quest campaigns, and 5-star proficiency system for drug categories
Embedded speaker icons provide human-recorded audio for brand and generic drug names
How much does it cost?
- Single purchase at $2.99
Flat-fee model at $2.99 provides full access to the drug database and gamification features without recurring costs.
Who Built It?
ClinCalc
Providing evidence-based clinical decision support and pharmacology education tools for healthcare professionals and students.
Portfolio
5
Apps
What other apps does ClinCalc make?
Explore the full ClinCalc report
Portfolio breakdown, audience, momentum, and every app published by ClinCalc.
What do users think recently?
Analysis in progress, available soon
View the full user-sentiment analysis
Mood gauge, ratings & review-volume history, every praise / complaint / request, and sentiment over time.
What is the competitive landscape for RxHero - Master Top 250 Drugs?
Where is it available?
Localized markets (1)
How's The Medical Market?
How does it evolve in the Medical market?
RxHero maintains a presence in the medical education category, though its lack of recent updates compared to subscription-based rivals limits its ability to capture new market share.
Rank progression
6 active rankings tracked — 30-day window
Which niche is RxHero - Master Top 250 Drugs in?
to master top 250 outpatient medications
Explore the full Pharmacology Flashcards niche
Every app in this space — 2 tracked, the niche's live rankings, and Marlvel's editorial take on the job-to-be-done.
The rivals identified
Same space(3)
Dominates the medication domain by focusing on patient adherence, creating a different but overlapping utility for drug knowledge.
Differentiators
- Provides real-time medication interaction alerts and personalized adherence tracking for end-users and caregivers.
- Includes a robust pill-identifier tool that visually assists users in verifying medication physical characteristics.
Provides a comprehensive medical knowledge base that competes for the same professional study time as RxHero.
Differentiators
- Features an integrated Qbank that links directly to high-yield medical articles for contextual learning.
- Offers a sophisticated 'Study Mode' that highlights key clinical concepts within complex medical literature.
While focused on nursing boards rather than pharmacology, it serves the same professional education market with high-frequency gamified testing.
Differentiators
- Utilizes a massive, verified question bank specifically mapped to current NCLEX nursing board standards.
- Integrates cross-platform progress synchronization allowing users to switch between mobile and desktop study sessions.
New entrants(1)
Shows high release velocity and focuses on the professional communication layer of the medical workflow.
Differentiators
- Integrates secure HIPAA-compliant messaging directly into the clinical workflow to replace fragmented communication tools.
- Provides a unified inbox that aggregates patient inquiries, phone calls, and internal team messages seamlessly.
Compare RxHero - Master Top 250 Drugs against every rival
All rivals in one side-by-side table — identity, store metrics, ratings & sentiment, and strategic intel — plus a head-to-head page for each.
The outtake for RxHero - Master Top 250 Drugs
Strengths to defend, gaps to attack
Core Strengths
- Leitner adaptive learning system provides a measurable study path
- Gamification milestones reduce churn via clear progress markers
- Audio pronunciation reinforces professional-grade authority
Critical Frictions
- Flat-fee pricing limits recurring revenue for updates
- No cross-platform synchronization for study sessions
- Lack of recent feature expansion
Growth Levers
- B2B distribution into pharmacy school partnerships
- Wearable integration for on-the-go drug fact review
Market Threats
- AMBOSS integrated Qbank creates higher-yield study environment
- Subscription-based rivals fund faster release cadences
- Clinical workflow tools threaten standalone study apps
What are the next best moves?
Ship cross-platform synchronization because users switch between mobile and desktop study environments → increase session utility
Competitors like NCLEX RN Mastery Exam offer cross-platform sync, creating a feature gap that limits RxHero's professional utility.
Trade-off: Push the wearable companion app sprint to Q3 — wearable waitlist is smaller than the core study-sync demand.
Audit content database for new drug approvals because the current list is based on older data → maintain exam-prep relevance
The database relies on older drug stats, which risks the app's reputation as an evidence-based tool for standardized exams.
Trade-off: Same-quarter capacity available — no major lever displaced.
A counter-intuitive read
The app's flat-fee pricing is a liability rather than a strength, as it prevents the continuous content investment required to compete with subscription-based medical knowledge platforms.
Feature Gaps vs Competitors
- Cross-platform progress synchronization (available in NCLEX RN Mastery Exam but missing here)
- Integrated Qbank linking to high-yield articles (available in AMBOSS but missing here)
Key Takeaways
RxHero provides a focused, gamified study tool for pharmacology, but the lack of cross-platform sync and recurring revenue for content updates leaves it vulnerable to subscription-based rivals, so the PM should prioritize cross-platform sync to defend the professional user base.
Where Is It Heading?
Stable
Medical education tools are shifting toward integrated, subscription-based platforms that link study content to clinical workflows. RxHero's standalone, one-time purchase model is increasingly exposed to these comprehensive rivals, so the PM must pivot to a more frequent update cadence or cross-platform utility to remain relevant.
The lack of recent feature expansion suggests a maintenance-mode posture, which allows competitors with faster release cadences to erode market share.
The flat-fee pricing model provides a low-barrier entry for students, but it limits the capital available for necessary content and feature updates.